Short interest in Biomarin Pharmaceutical Inc (NASDAQ:BMRN) decreased during the last reporting period, falling from 5.59M to 5.38M. This put 2.84% of the company's publicly available shares short.

Short interest for Biomarin Pharmaceutical gives investors a sense of the degree to which investors are betting on the decline of Biomarin Pharmaceutical's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.51M shares traded per day, it would take 3.57 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.